Filter
717
Text search:
medicines
and
related
substances
Featured
Recommendations
92
New Publications
192
Language
Document type
No document type
370
Guidelines
144
Studies & Reports
87
Manuals
59
Strategic & Response Plan
25
Training Material
17
Situation Updates
6
Resource Platforms
3
Fact sheets
3
Brochures
2
Infographics
1
Countries / Regions
South Africa
40
India
39
Kenya
32
Western and Central Europe
22
Zambia
18
Nigeria
17
Ethiopia
17
Global
17
Uganda
16
Ghana
15
Sierra Leone
12
Nepal
11
Tanzania
11
Namibia
10
Eswatini/ Swaziland
9
Liberia
8
Zimbabwe
8
Indonesia
8
Ukraine
8
Myanmar / Burma
8
Botswana
7
Africa
7
Syria
6
Rwanda
6
Philippines
5
Bangladesh
5
Malawi
5
Eastern Europe
5
Pakistan
4
Cambodia
4
North Macedonia
4
South–East Asia Region
4
Latin America and the Carribbean
4
Lesotho
3
Eastern Europe and Central Asia
3
Moldova
3
Afghanistan
2
Germany
2
Thailand
2
Hungary
2
Sri Lanka
2
Bhutan
2
Poland
2
Tajikistan
2
Kyrgyzstan
2
Georgia
2
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Morocco
1
Cameroon
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Mozambique
1
Sudan
1
Argentina
1
Brazil
1
Switzerland
1
Serbia
1
Colombia
1
Libya
1
Mexico
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Southern Africa
1
Russia
1
Iran
1
Kazakhstan
1
Jamaica
1
Maldives
1
Mauritius
1
United Kingdom
1
Norway
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
301
Clinical Guidelines
52
Public Health
29
Women & Child Health
23
Pharmacy & Technologies
17
Capacity Building
16
Key Resources
13
Protection & Security
1
Toolboxes
Mental Health
91
Pharmacy
85
AMR
66
HIV
43
TB
25
COVID-19
24
Caregiver
23
Planetary Health
17
Conflict
15
Rapid Response
15
NCDs
15
Ebola
11
Specific Hazards
7
Global Health Education
6
Refugee
5
Natural Hazards
3
Zika
2
NTDs
2
Health Financing Toolbox
2
Disability
1
Cholera
1
Polio
1
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Chil
...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure impo
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation
...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and
...
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased mor
...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; o
...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality
...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,
...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledg
...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used
...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on stor
...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational use of
...
The attainment of Zambia’s goal of being a prosperous and middle-income country by 2030 as stipulated in its Vision 2030 is dependent on among others, a healthy and productive population. Therefor
...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO
...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop
...
